CUX1在髓系肿瘤中的独特临床与生物学意义
该研究利用1480例髓系肿瘤患者队列,分析CUX1突变(CUX1 MT)与CUX1缺失(CUX1 DEL)的临床特征、克隆层级及体外功能后果。CUX1 MT见于4%慢性髓系肿瘤,CUX1 DEL偏好见于晚期病例(6%);CUX1 MT/DEL与CUX1 WT相比生存更差。功能实验显示CUX1病变导致氧化碱基修复缺陷,可能解释其突变负荷增高,提示DNA修复功能障碍参与髓系肿瘤发病。
要点
- CUX1 MT见于4%慢性髓系肿瘤,CUX1 DEL偏好见于晚期病例(6%)。
- CUX1 MT/DEL与CUX1 WT相比生存更差。
- CUX1病变导致氧化碱基修复缺陷,可能形成突变表型。
核心结论
- CUX1病变导致的DNA修复功能障碍参与髓系肿瘤发病,并导致突变表型。
研究设计与样本
- 利用1480例髓系肿瘤患者队列表征CUX1 MT和CUX1 DEL的临床特征与克隆层级,并进行体外功能分析。
主要发现
- CUX1 MT见于4%慢性髓系肿瘤,CUX1 DEL偏好见于晚期病例(6%)。
- 多数伴-7/del(7q)的MDS和AML患者及高达15%的CUX1位点二倍体MDS患者和5%的AML患者显示CUX1表达下调。
- 75%的突变病例中CUX1 MT为杂合,微缺失及纯合和复合杂合突变较少见。
- CUX1 MT/DEL与CUX1 WT相比生存更差。
- 克隆层级中1/3的CUX1 MT作为创始事件常继以BCOR和ASXL1亚克隆打击,而TET2是最常见祖先病变。
关键数值与推荐
- CUX1 MT见于4%慢性髓系肿瘤,CUX1 DEL见于6%晚期病例。
- 高达15%的CUX1位点二倍体MDS患者和5%的AML患者显示CUX1表达下调。
- 75%的突变病例中CUX1 MT为杂合。
- 1/3的CUX1 MT作为创始事件。
临床怎么用
- 原文未报告临床实践建议。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Somatic mutations of the CUT-like homeobox 1 (CUX1) gene (CUX1 MT) can be found in myeloid neoplasms (MNs), in particular, in myelodysplastic syndromes (MDSs). The CUX1 locus is also deleted in 3 of 4 MN cases with -7/del(7q). A cohort of 1480 MN patients was used to characterize clinical features and clonal hierarchy associated with CUX1 MT and CUX1 deletions (CUX1 DEL) and to analyze their functional consequences in vitro. CUX1 MT were present in 4% of chronic MNs. CUX1 DEL were preferentially found in advanced cases (6%). Most MDS and acute myeloid leukemia (AML) patients with -7/del(7q) and up to 15% of MDS patients and 5% of AML patients diploid for the CUX1 locus exhibited downmodulated CUX1 expression. In 75% of mutant cases, CUX1 MT were heterozygous, whereas microdeletions and homozygous and compound-heterozygous mutations were less common. CUX MT/DEL were associated with worse survival compared with CUX1 WT Within the clonal hierarchy, 1 of 3 CUX1 MT served as founder events often followed by secondary BCOR and ASXL1 subclonal hits, whereas TET2 was the most common ancestral lesion, followed by subclonal CUX1 MT Comet assay of patients' bone marrow progenitor cells and leukemic cell lines performed in various experimental conditions revealed that frameshift mutations, hemizygous deletions, or experimental CUX1 knockdown decrease the repair of oxidized bases. These functional findings may explain why samples with either CUX1 MT or low CUX1 expression coincided with significantly higher numbers of somatic hits by whole-exome sequencing. Our findings implicate the DNA repair dysfunction resulting from CUX1 lesions in the pathogenesis of MNs, in which they lead to a mutator phenotype.
引用
- Aly M, Ramdzan ZM, Nagata Y, et al. Distinct clinical and biological implications of CUX1 in myeloid neoplasms. Blood Adv. 2019. PMID: 31320321. doi:10.1182/bloodadvances.2018028423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。